Goodwin
Heath Ingram
- Deals
- 4
- Latest
- May 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 4 deals
Often works with
- Dan Karelitz 3 deals together
- Malhar Naik 3 deals together
- Arman Oruc 2 deals together
- Julie Tibbets 2 deals together
- Kevin Walsh 2 deals together
- Benjamin Gossels 2 deals together
- Elizabeth Mulkey 2 deals together
- Samuel Beavers 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| May 2026 | LimmaTech Biologics AG | – | Eli Lilly and Company | Acquisition | Legal adviser to LimmaTech Biologics AG (target) | Pending | 780.0 | Biotech | Eli Lilly and Company acquisition of LimmaTech Biologics AG |
| Apr 2026 | CathWorks | – | Medtronic | Acquisition | Legal adviser to CathWorks (target) | Announced | 585.0 | Medtech+1 | Medtronic acquisition of CathWorks |
| Apr 2026 | Worldwide rights to Kenalog | Bristol-Myers Squibb | Subsidiary of Piramal Pharma | Asset sale | Legal adviser to subsidiary of Piramal Pharma (acquirer) | Announced | 35.0 | Pharma | Subsidiary of Piramal Pharma acquisition of Worldwide rights to Kenalog |
| Mar 2026 | Pikavation | Synnovation | Novartis | Acquisition | Legal adviser to Synnovation Therapeutics (seller) | Announced | 2,000.0 | Biotech+2 | Novartis acquisition of Pikavation |
Deals where Heath Ingram is named on the firm's deal team, by the firm or the press.